NCT05864976 Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
| NCT ID | NCT05864976 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Glioblastoma Multiforme |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-12-06 |
| Primary Completion | 2030-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-12-06 with a primary completion date of 2030-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is investigating the use of a computer algorithm to analyze scans of the brain before surgery to predict how a person's tumor will respond to treatment.
Eligibility Criteria
Inclusion Criteria: * Must have a radiological diagnosis of a lesion in the brain with characteristics consistent with glioblastoma multiforme. * Must be planning to undergo a pre-operative MRI. * Must be at least 18 years old. * Must be able to understand and willing to sign an IRB approved written informed consent document. Exclusion Criteria: * Contraindication to MRI. * Inability to have clinical follow-up (e.g., patient is out of town and will do follow-up elsewhere).
Contact & Investigator
Dimitrios Mathios, M.D.
PRINCIPAL INVESTIGATOR
Washington University School of Medicine
Frequently Asked Questions
Who can join the NCT05864976 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Glioblastoma Multiforme. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05864976 currently recruiting?
Yes, NCT05864976 is actively recruiting participants. Contact the research team at mathios@wustl.edu for enrollment information.
Where is the NCT05864976 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT05864976 clinical trial?
NCT05864976 is sponsored by Washington University School of Medicine. The principal investigator is Dimitrios Mathios, M.D. at Washington University School of Medicine. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.